Cite Filings / OSTX / 0001493152-25-002859
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13D

Beneficial Ownership Report

OS Therapies Inc · Filed 2025-01-17 · Acc 0001493152-25-002859

Documents 1

  • SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

  • 2025-01-17 SCHEDULE 13D Beneficial Ownership Report
  • 2025-01-17 4 10% owner sold 16,720 shares at $6.74 ($112,609)
  • 2025-01-15 8-K Other events
  • 2025-01-14 4 10% owner acquired 1,766,927 shares (conversion)
  • 2025-01-14 3 Initial Statement of Ownership
  • 2025-01-14 8-K Material agreement · Unregistered share sale
  • 2025-01-13 EFFECT Notice of Effectiveness

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…